Showing results (1671-1680 of 1,745) with videos related to

Sort By:
Pageof 175
Blood|October 24, 2002
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)John C Byrd, Krzysztof Mrózek, Richard K Dodge, et al.
Leukemia|September 24, 2010
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutationsT Zenz, D Vollmer, M Trbusek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2017
Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trialT E Witzig, K Tobinai, L Rigacci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2019
Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405Brendan J Guercio, Sui Zhang, Fang-Shu Ou, et al.
JNCI Cancer Spectrum|November 2, 2020
Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405Brendan J Guercio, Sui Zhang, Alan P Venook, et al.
Plos One|July 20, 2018
Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)Brendan J Guercio, Sui Zhang, Donna Niedzwiecki, et al.
Molecular Therapy. Nucleic Acids|January 17, 2013
Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic FibrosisKenneth L Clark, Stephen A Hughes, Pallav Bulsara, et al.
JAMA Network Open|October 30, 2020
Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 TrialErin L Van Blarigan, Sui Zhang, Fang-Shu Ou, et al.
JAMA|June 21, 2017
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical TrialAlan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, et al.
Leukemia|October 14, 2018
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphomaG Fraser, P Cramer, F Demirkan, et al.
Pageof 175